S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
Conditions:   Prevention & Control;   Diarrhea Caused by Drug;   Respiratory Infection Bacterial;   Anti-Bacterial Agents Intervention:   Drug: drug product: capsules are containing S. boulardii, administered twice daily (250 mg) Sponsors:   Clinical Centre of Serbia;   Institute for Pulmonary Diseases of Vojvodina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials